Similarly, Luteolin, was known to suppress the stemness of prostate cancer cells by inhibiting the Wnt signaling via transcriptional upregulation of frizzle class receptor 6 (FZD6) (Li et al., 2018). Here, FZD6 is linked to prostate cancer.